Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

U.S. DEA Temporarily Bans Synthetic Opioid “Pink” after 46 Deaths

By Natalie Grover | on December 13, 2016 | 0 Comment
Latest News Uncategorized
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

(Reuters) – The U.S. Drug Enforcement Administration (DEA) said on Thursday it had temporarily categorized a synthetic opioid nicknamed “pink” as a dangerous drug, after receiving at least 46 reports of deaths associated with its use. The abuse of opioids – a class of drugs that includes heroin and prescription painkillers – has reached epidemic proportions in the United States. The Centers for Disease Control and Prevention estimates that 78 Americans die every day from opioid overdose.

You Might Also Like
  • DEA Proposes Cutting Production of Some Opioid Painkillers
  • Mallinckrodt Settles U.S. Opioid Drug Probe for $35 Million
  • Boston Bans “Synthetic Marijuana”

“Pink”, known to chemists as U-47700, comes from a family of deadly synthetic opioids that are far more potent than heroin, and is usually imported to the United States mainly from China. It gets its name from the pink-purple hue that comes from the way it is cut or processed.

The DEA said it had temporarily categorized U-47700 as a “Schedule 1” substance, effective Nov. 14, classifying it as a dangerous addictive drug with no medicinal use, placing it on par with heroin, cannabis and LSD. The scheduling will last for two years, with a possible one-year extension if the DEA requires more data to determine whether it should be permanently scheduled, the agency said.

Of the 46 fatalities, 31 occurred in New York and 10 in North Carolina, the DEA said, from reports it received between Oct. 2015 and Sept. 2016. Law enforcement agencies have seized the drug in powder form and counterfeit tablets that mimic prescription opioid painkillers, the agency said.

Since substances like U-47700 are often made in illicit labs overseas, their identity, purity, and quantity are unknown, creating a ‘Russian roulette’ scenario for users, the DEA said.

In March, law enforcement agencies in Ohio seized 500 blue pills that visually appeared to be short-acting oxycodone pills, but a laboratory analysis confirmed they were U-47700.

Topics: AddictionDEAOpioidOpioid abusePublic Health

Related

  • Dr. Joe Sachs and “The Pitt” Redefine Public Health Education Through Storytelling

    July 3, 2025 - 0 Comment
  • Dr. Joe Sachs and “The Pitt” Are Redefining Public Health Education Through Storytelling

    June 11, 2025 - 0 Comment
  • May 2023 News From the College

    May 1, 2023 - 0 Comment

Current Issue

ACEP Now: July 2025

Download PDF

Read More

No Responses to “U.S. DEA Temporarily Bans Synthetic Opioid “Pink” after 46 Deaths”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Current Issue

ACEP Now: July 2025

Download PDF

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603